SpyGlass Pharma成立于2019年，计划在纳斯达克挂牌上市，股票代码为"SGP"。Jefferies、Leerink Partners、花旗及Stifel为此次IPO的联席簿记管理人。 SpyGlass Pharma是一家临床后期生物制药企业，聚焦慢性眼病领域，专注于通过开发持久的给药解决 方案来治疗慢性眼病，以实现长期疾病控制和视力保护。公司核心在研产品为比马前列素药垫人工晶状 体系统(BIM-IOL系统)，该系统将自主研发的新型药垫与人工晶状体相结合，可在常规白内障手术中完 成植入，用于降低开角型青光眼(OAG)或高眼压症(OHT)患者的升高眼压。此外，公司还在研发一款非 人工晶状体载体的比马前列素环形缓释植入物，该产品可通过独立手术完成植入，既可为已植入BIM- IOL系统的患者提供二次治疗方案，也能为既往接受过白内障手术的开角型青光眼或高眼压症患者提供 延续性治疗。 专注慢性眼病治疗植入物研发、处于三期临床试验阶段的生物科技企业SpyGlass Pharma(SGP.US)于周四 公布其首次公开发行(IPO)的发行条款。这家总部位于美国加利福尼亚州阿利索维耶霍市的企业，计划 以每股15-1 ...

Registration No. 333-292779 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO FORM S-1 As filed with the Securities and Exchange Commission on January 29, 2026. REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 SpyGlass Pharma, Inc. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) Delaware 3841 83-3044245 (I.R.S. Employer Identification ...

Core Viewpoint - SpyGlass Pharma, Inc. has filed to raise $100 million in an IPO of its common stock, with the final amount subject to change [1] Group 1: Company Overview - SpyGlass Pharma, Inc. is preparing for an initial public offering (IPO) to raise $100 million [1] Group 2: IPO Insights - Donovan Jones, an IPO research specialist with 15 years of experience, leads the investing group IPO Edge, which provides actionable information on growth stocks and IPOs [1] - IPO Edge offers resources including first-look IPO filings, previews on upcoming IPOs, an IPO calendar, a database of U.S. IPOs, and a guide to IPO investing [1]

As filed with the Securities and Exchange Commission on January 16, 2026. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 SpyGlass Pharma, Inc. (Exact name of registrant as specified in its charter) (State or other jurisdiction of (Primary Standard Industrial Classification Code Number) Delaware 3841 83-3044245 (I.R.S. Employer Identification Number) 27061 Aliso Creek Rd., Suite 100 Aliso Viejo, Ca ...